When it comes to treating cancer, chemotherapy is usually the well-travelled route, but along with the treatment comes several side-effects, none of which are too pleasant for the person undergoing said treatment. Side-effects include the weakening of the immune system, fatigue, hair loss, and last but not least, nausea and vomiting. Chicago-based Neurowave Medical Technologies has released a new medical device that the company claims will help to prevent nausea and vomiting.
The device in question is called Nometex and it resembles a wrist-watch. How it works is it uses a method by NMT which is a non-drug treatment that relies on the company’s proprietary neuromodulation technology platform to positively modulate neural pathways using electrical pulses for prophylaxis, breakthrough, or refractory CINV (chemotherapy-induce nausea and vomiting).
It is said to be able to offer patients a rapid onset of action, usually within minutes, and is said to reduce the side-effects of CINV that are normally treated with pharmaceuticals. Their first model, the Nometex N2C, is reported to provide up to 150 hours of therapy, which the company claims will be able to help most patients through two cycles worth of therapy.
At the moment it does not appear that the device can be bought off the shelves, but NMT will be releasing more of the Nemotex to over 1,700 Oncology clinics within the US.